Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,861,515
-
Share change
-
-438,709
-
Total reported value
-
$2,670,063,873
-
Put/Call ratio
-
24%
-
Price per share
-
$74.45
-
Number of holders
-
245
-
Value change
-
-$48,294,193
-
Number of buys
-
107
-
Number of sells
-
155
Institutional Holders of CANTEL MEDICAL CORP - COM (CMD) as of Q4 2018
As of 31 Dec 2018,
CANTEL MEDICAL CORP - COM (CMD) was held by
245 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,861,515 shares.
The largest 10 holders included
BlackRock Inc., BROWN CAPITAL MANAGEMENT LLC, Vanguard Group Inc, WASATCH ADVISORS INC, Neuberger Berman Group LLC, FRED ALGER MANAGEMENT INC, DIKER MANAGEMENT LLC, Conestoga Capital Advisors, LLC, STATE STREET CORP, and Champlain Investment Partners, LLC.
This page lists
245
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.